24/7 Patient Assistance: 760-405-8205

Kambarajapuram Desikan, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

Hospitals & Clinics

  • Bio & Insurance Information

    Dr. Kambarajapuram Desikan is a medical oncologist from Little Rock, Arkansas and he works at White River Medical Center. He got his diploma from Madras Medical College and did a fellowship in Medical Oncology at the top University of Arkansas for Medical Sciences and one in Hematology at St Elizabeth's Medical Center. The doctor is certified in Hematology, Internal Medicine, Medical Oncology and has an experience of more than 20 years.



  • Education & Training

    dept_icon

    Madras Medical College

    Medical School

    dept_icon

    St Elizabeth's Medical Center

    Fellowship

    dept_icon

    University of Arkansas for Medical Sciences

    Fellowship

  • Board Certifications

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    White River Medical Center

    Languages: English/Spanish

    (870) 262-1200

    1710 Harrison St

    Batesville, Arkansas 72501

    Read More
  • Publications & Memberships

    Dr. Kambarajapuram Desikan has contributed to 3 publications.

    382 citations A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma.

    Richardson, P. G., Blood, E., Mitsiades, C. S., Jagannath, S., Zeldenrust, S. R., Alsina, M., Schlossman, R. L., Rajkumar, S. V., Desikan, K. R., Hideshima, T., Munshi...; Blood. 2006 Nov 15.

    See more >>

    2 citations Expression of a free gamma heavy chain in serum following autologous stem cell transplantation for IgG kappa multiple myeloma.

    Butch, A. W., Badros, A., Desikan, K. R., Munshi, N. C.; Bone Marrow Transplant. 2001 Mar.

    See more >>

    Preceding chemotherapy, tumour load and age influence engraftment in multiple myeloma patients mobilized with granulocyte colony-stimulating factor alone.

    Desikan, K. R., Tricot, G., Munshi, N. C., Anaissie, E., Spoon, D., Fassas, A., Toor, A., Zangari, M., Badros, A., Morris, C., Vesole, D. H., Siegel, D., Jagannath, S....; Br J Haematol. 2001 Jan.

    See more >>